Literature DB >> 21324870

Maternal selenium status during early gestation and risk for preterm birth.

Margaret P Rayman1, Hennie Wijnen, Huib Vader, Libbe Kooistra, Victor Pop.   

Abstract

BACKGROUND: Preterm birth occurs in 5%-13% of pregnancies. It is a leading cause of perinatal mortality and morbidity and has adverse long-term consequences for the health of the child. Because of the role selenium plays in attenuating inflammation, and because low concentrations of selenium have been found in women with preeclampsia, we hypothesized that low maternal selenium status during early gestation would increase the risk of preterm birth.
METHODS: White Dutch women with a singleton pregnancy (n = 1197) were followed prospectively from 12 weeks' gestation. Women with thyroid disease or type 1 diabetes were excluded. At delivery, 1129 women had complete birth-outcome data. Serum concentrations of selenium were measured during the 12th week of pregnancy. Deliveries were classified as preterm or term, and preterm births were subcategorized as iatrogenic, spontaneous or the result of premature rupture of the membranes.
RESULTS: Of the 60 women (5.3%) who had a preterm birth, 21 had premature rupture of the membranes and 13 had preeclampsia. The serum selenium concentration at 12 weeks' gestation was significantly lower among women who had a preterm birth than among those who delivered at term (mean 0.96 [standard deviation (SD) 0.14] μmol/L v. 1.02 [SD 0.13] μmol/L; t = 2.9, p = 0.001). Women were grouped by quartile of serum selenium concentration at 12 weeks' gestation. The number of women who had a preterm birth significantly differed by quartile (χ² = 8.01, 3 degrees of freedom], p < 0.05). Women in the lowest quartile of serum selenium had twice the risk of preterm birth as women in the upper three quartiles, even after adjustment for the occurrence of preeclampsia (adjusted odds ratio 2.18, 95% confidence interval 1.25-3.77).
INTERPRETATION: Having low serum selenium at the end of the first trimester was related to preterm birth and was independent of the mother having preeclampsia. Low maternal selenium status during early gestation may increase the risk of preterm premature rupture of the membranes, which is a major cause of preterm birth.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324870      PMCID: PMC3060183          DOI: 10.1503/cmaj.101095

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  41 in total

1.  The influence of the cytokines Il-1beta and INFgamma on the expression of selenoproteins in the human hepatocarcinoma cell line HepG2.

Authors:  K Hesse-Bähr; I Dreher; J Köhrle
Journal:  Biofactors       Date:  2000       Impact factor: 6.113

2.  Plasma selenium in preterm and term infants during the first 12 months of life.

Authors:  E Sievers; T Arpe; U Schleyerbach; D Garbe-Schönberg; J Schaub
Journal:  J Trace Elem Med Biol       Date:  2001-04       Impact factor: 3.849

Review 3.  Selenium-dependent enzymes in endothelial cell function.

Authors:  Regina Brigelius-Flohé; Antje Banning; Kerstin Schnurr
Journal:  Antioxid Redox Signal       Date:  2003-04       Impact factor: 8.401

4.  Modulation of the thioredoxin system during inflammatory responses and its effect on heme oxygenase-1 expression.

Authors:  Kuniaki Ejima; Matthew D Layne; Irvith M Carvajal; Hiroki Nanri; Bonna Ith; Shaw-Fang Yet; Mark A Perrella
Journal:  Antioxid Redox Signal       Date:  2002-08       Impact factor: 8.401

5.  Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2.

Authors:  Tzong-Shyuan Lee; Hui-Ling Tsai; Lee-Young Chau
Journal:  J Biol Chem       Date:  2003-03-17       Impact factor: 5.157

6.  Predictors of toenail selenium levels in men and women.

Authors:  P A van den Brandt; R A Goldbohm; P van't Veer; P Bode; R J Hermus; F Sturmans
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1993 Mar-Apr       Impact factor: 4.254

7.  [Changes in selenium in patients with pregnancy-induced hypertension].

Authors:  B Y Lu
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  1990-11

8.  Low selenium status is associated with the occurrence of the pregnancy disease preeclampsia in women from the United Kingdom.

Authors:  Margaret P Rayman; Peter Bode; Christopher W G Redman
Journal:  Am J Obstet Gynecol       Date:  2003-11       Impact factor: 8.661

9.  Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides.

Authors:  S W Walsh; Y Wang
Journal:  Am J Obstet Gynecol       Date:  1993-12       Impact factor: 8.661

10.  Selenium supplement in the prevention of pregnancy induced hypertension.

Authors:  L Han; S M Zhou
Journal:  Chin Med J (Engl)       Date:  1994-11       Impact factor: 2.628

View more
  31 in total

1.  Placental Metal Concentrations in Relation to Maternal and Infant Toenails in a U.S. Cohort.

Authors:  Tracy Punshon; Zhigang Li; Carmen J Marsit; Brian P Jackson; Emily R Baker; Margaret R Karagas
Journal:  Environ Sci Technol       Date:  2016-01-15       Impact factor: 9.028

2.  Placental transfer and concentrations of cadmium, mercury, lead, and selenium in mothers, newborns, and young children.

Authors:  Zhu Chen; Robert Myers; Taiyin Wei; Eric Bind; Prince Kassim; Guoying Wang; Yuelong Ji; Xiumei Hong; Deanna Caruso; Tami Bartell; Yiwei Gong; Paul Strickland; Ana Navas-Acien; Eliseo Guallar; Xiaobin Wang
Journal:  J Expo Sci Environ Epidemiol       Date:  2014-04-23       Impact factor: 5.563

3.  Maternal exposure to selenium and cadmium, fetal growth, and placental expression of steroidogenic and apoptotic genes.

Authors:  Todd M Everson; Maya Kappil; Ke Hao; Brian P Jackson; Tracy Punshon; Margaret R Karagas; Jia Chen; Carmen J Marsit
Journal:  Environ Res       Date:  2017-07-03       Impact factor: 6.498

Review 4.  Oxidative stress in pregnancy and reproduction.

Authors:  Kate Duhig; Lucy C Chappell; Andrew H Shennan
Journal:  Obstet Med       Date:  2016-05-17

5.  Effect of Iodine and Selenium on Proliferation, Viability, and Oxidative Stress in HTR-8/SVneo Placental Cells.

Authors:  Nahal Habibi; Tanja Jankovic-Karasoulos; Shalem Yiner-Lee Leemaqz; Maxime Francois; Shao Jia Zhou; Wayne R Leifert; Anthony V Perkins; Claire T Roberts; Tina Bianco-Miotto
Journal:  Biol Trace Elem Res       Date:  2020-07-05       Impact factor: 3.738

6.  Dietary factors and luteal phase deficiency in healthy eumenorrheic women.

Authors:  Mary A Andrews; Karen C Schliep; Jean Wactawski-Wende; Joseph B Stanford; Shvetha M Zarek; Rose G Radin; Lindsey A Sjaarda; Neil J Perkins; Robyn A Kalwerisky; Ahmad O Hammoud; Sunni L Mumford
Journal:  Hum Reprod       Date:  2015-06-16       Impact factor: 6.918

7.  Manganese is associated with increased plasma interleukin-1β during pregnancy, within a mixtures analysis framework of urinary trace metals.

Authors:  Max T Aung; John D Meeker; Jonathan Boss; Kelly M Bakulski; Bhramar Mukherjee; David E Cantonwine; Thomas F McElrath; Kelly K Ferguson
Journal:  Reprod Toxicol       Date:  2019-12-24       Impact factor: 3.143

8.  Urinary trace metals individually and in mixtures in association with preterm birth.

Authors:  Stephani S Kim; John D Meeker; Rachel Carroll; Shanshan Zhao; Michael J Mourgas; Michael J Richards; Max Aung; David E Cantonwine; Thomas F McElrath; Kelly K Ferguson
Journal:  Environ Int       Date:  2018-10-06       Impact factor: 9.621

Review 9.  Fetal Programming Is Deeply Related to Maternal Selenium Status and Oxidative Balance; Experimental Offspring Health Repercussions.

Authors:  María Luisa Ojeda; Fátima Nogales; Inés Romero-Herrera; Olimpia Carreras
Journal:  Nutrients       Date:  2021-06-18       Impact factor: 5.717

Review 10.  The effects of oxidative stress on female reproduction: a review.

Authors:  Ashok Agarwal; Anamar Aponte-Mellado; Beena J Premkumar; Amani Shaman; Sajal Gupta
Journal:  Reprod Biol Endocrinol       Date:  2012-06-29       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.